Vai al contenuto principale della pagina
Titolo: |
Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017
![]() |
Pubblicazione: | Washington : , : U.S. Government Publishing Office, , 2018 |
Descrizione fisica: | 1 online resource (v, 136 pages) : illustrations |
Soggetto topico: | User charges - Law and legislation |
Prescription pricing - Law and legislation | |
Generic drugs - Prices | |
Drugs - Law and legislation | |
Generic drugs - Prices - United States | |
Prescription pricing - Law and legislation - United States | |
User charges - Law and legislation - United States | |
Drug accessibility - Government policy - United States | |
Drugs - Law and legislation - United States | |
Soggetto geografico: | United States |
Soggetto genere / forma: | Rules. |
Legislative hearings. | |
Note generali: | "Serial No. 115-10." |
Nota di bibliografia: | Includes bibliographical references. |
Altri titoli varianti: | Examining FDA's generic drug and biosimilar user fee programs |
Titolo autorizzato: | Examining FDA's generic drug and biosimilar user fee programs ![]() |
Formato: | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione: | Inglese |
Record Nr.: | 9910716666403321 |
Lo trovi qui: | Univ. Federico II |
Opac: | Controlla la disponibilità qui |